Development of Serologic Assays for Human Herpes Virus-8



Status:Active, not recruiting
Conditions:Infectious Disease, HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - 99
Updated:1/25/2019
Start Date:October 30, 2006

Use our guide to learn which trials are right for you!

Dr. Burbelo and colleagues have developed a technique for rapidly and quantitatively
detecting antibody responses in sera to a variety of pathogens using recombinant proteins. We
would like to apply this technique to develop an assay for detecting antibodies to HHV-8
(KSHV, the etiologic agents of Kaposi's sarcoma, an AIDS-defining condition). We initially
plan to examine samples from patients with Kaposi's sarcoma, since all those patients are
almost certainly infected with HHV-8. We are thus using samples from patients with previously
diagnosed Kaposi's sarcoma. The samples in question are stored at the NCI FCRF repository
operated by SAIC Frederick or in Rockville, MD.

Our colleagues have developed a technique for rapidly and quantitatively detecting antibody
responses in sera to a variety of antigens using recombinant proteins. We would like to apply
this technique to develop an assay for detecting antibodies to HHV- 8 (KSHV, the etiologic
agent of Kaposi s sarcoma, an AIDS-defining condition). In addition we would like to
potentially measure antibody responses to HIV, other infectious agents, and human antigens,
to see if antibodies (or high antibody titers) to these antigens are associated with Kaposi s
sarcoma or HIV infection. We initially plan to examine samples from patients with Kaposi s
sarcoma, since all those patients are almost certainly infected with HHV-8. We would
subsequently plan to examine samples from HIV positive and HIV negative patients without
known Kaposi s sarcoma. We are thus requesting permission to use samples from patients with
and without previously diagnosed Kaposi's Sarcoma. In addition to antibody testing, we would
also like to examine these samples for evidence of infection with other infectious agents,
such as newly identified or unknown viruses, using techniques such as PCR or deep

sequencing.

- Data analysis only
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
?
mi
from
Bethesda, MD
Click here to add this to my saved trials